References

1. Hall EJ, German AJ. Diseases of the small intestine. In: Ettinger SJ, Feldman EC (eds.) Textbook of Veterinary Internal Medicine, 6th ed. Philadelphia, WB Saunders, 2005; 1332-1378.

2. Craven M, Simpson JW Ridyard AE et al. Canine inflammatory bowel disease: retrospective analysis of diagnosis and outcome in 80 cases (1995-2002).J Small Anim Pract 2004; 45: 336-342.

3. Elson CO. Experimental models of intestinal inflammation: New insights into mechanisms of mucosal homeostasis. In: Ogra PL, Mestecky J, Lamm ME, Strober W, Bienenstock J, McGhee JR (eds.) Mucosal Immunology, 2nd ed. San Diego Ca, Academic Press, 1999; 1007-1034.

4. Karp LC, Targan SR. Ulcerative colitis: evidence for an updated hy­pothesis of disease pathogenesis. In: Ogra PL, Mestecky J, Lamm ME et al. (eds.), Mucosal Immunology, 2nd ed. San Diego Ca, Academic Press, 1999; 1047-1053.

5. Duchmann R, Zeitz M. Crohn's disease. In: Ogra PL, Mestecky J, Lamm ME et al. (eds.), Mucosal Immunology, 2nd ed. San Diego Ca, Academic Press, 1999; 1055-1080.

6. Hugot JP, Chamaillard M, Zouali H et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 2001; 411: 599-603.

7. Ogura Y, Bonen DK, Inohara N et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 2001; 411:603-606.

8. Johnston KL. Small intestinal bacterial overgrowth. Vet Clin N Am Small Anim Pract 1999; 29: 523-550.

9. Kelsall B, Strober W. Gut-associated lymphoid tissue antigen handling and T-lymphocyte responses. In: Ogra PL, Mestecky J, Lamm ME et al. (eds.), Mucosal Immunology, 2nd ed. San Diego Ca, Academic Press, 1999; 293-318.

10. German AJ, Hall EJ, Day MJ. Chronic intestinal inflammation and intestinal disease in dogs. J Vet Intern Med 2003; 17: 8-20.

11. German AJ, Hall EJ, Moore PF et al. Analysis of the distribution of lymphocytes expressing αβ and γδ T cell receptors, and the expres­sion of mucosal addressin cell adhesion molecule-1 in the canine intestine.

12. German AJ, Hall EJ, Day MJ. Analysis of leucocyte subsets in the canine intestine. J Comp Pathol 1999; 120: 129-145.

13. Elwood CM, Hamblin AS, Batt RM. Quantitative and qualitative immunohistochemistry of T cell subsets and MHC class II expres­sion in the canine intestine. Vet Immunol Immunopathol 1997; 58: 195-207.

14. Waly N, Gruffydd-Jones TJ, Stokes CR et al. The distribution of leucocyte subsets in the small intestine of normal cats.J Comp Pathol 2001;124:172-182.

15. Mosmann TR, Cherwinski H, Bond MW et al. Two types of murine helper T-cell clones. I. Definition according to profiles of lymphokine activities and secreted proteins.J Immunol 1986; 136: 2348-2357.

16. Groux H, OGarra A, Bigler M et al.A CD4+ T-cell inhibits antigen­specific T cell responses and prevents colitis. Nature 1997; 389: 737­742.

17. German AJ, Bland PW Hall EJ et al. Expression of major histocom­patibility complex class II antigens in the canine intestine. Vet Im­munol Immunopathol 1998; 61: 171-180.

18. Mowat AM,Weiner HL. Oral tolerance: physiological basis and clinical applications. In: Ogra PL, Mestecky J, Lamm ME et al. (eds.) Mucosal Immunology, 2nd ed. San Diego Ca, Academic Press, 1999; 587-618.

19. Matzinger P. Tolerance, danger and the extended family. Ann Rev Immunol 1994; 12: 991-1045.

20. Madsen KL, Doyle JS, Jewell LD et al. Lactobacillus species prevents colitis in interleukin 10 gene-deficient mice. Gastroenterology 1999; 116: 1107-1114.

21. Duchmann R, Kaiser I, Hermann E et al. Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease (IBD). Clin Exp Immunol 1995; 102: 448-455.

22. Weiss DJ, Gagne JM, Armstrong PJ. Relationship between inflam­matory hepatic disease and inflammatory bowel disease, pancreatitis, and nephritis in cats.J Am Vet Med Assoc 1996; 209: 1114-1116.

23. Jergens AE. Inflammatory bowel disease - current perspectives. Vet Clin N Am Small Anim Pract 1999; 29: 501-521.

24. Morgan LW, McConnell J. Cobalamin deficiency associated with erythroblastic anemia and methylmalonic aciduria in a Border Col­lie. J Am Anim Hosp Assoc 1999; 35: 392-395.

25. Baez JL, Hendrick MJ, Walker LM et al. Radiographic, ultrasono­graphic, and endoscopic findings in cats with inflammatory bowel disease of the stomach and small intestine: 33 cases (1990-1997). J Am Vet Med Assoc 1999; 215: 349-354.

26. Goggin JM, Biller DS, Debey BM et al. Ultrasonographic measure­ment of gastrointestinal wall thickness and the ultrasonographic ap­pearance of the ileocolic region in healthy cats. J Am Anim Hosp Assoc 2000; 36: 224-228.

27. Rudorf H, O'Brien R, Barr FJ et al. Ultrasonographic evaluation of the small intestinal wall thickness in dogs with inflammatory bowel disease from the UK. J Small Anim Pract, in press

28. Willard MD, Lovering SL, Cohen ND et al. Quality of tissue speci­mens obtained endoscopically from the duodenum of dogs and cats. JAm Vet Med Assoc 2001; 219: 474-479.

29. Willard MD, Jergens AE, Duncan RB et al. Interobserver variation among histopathologic evaluations of intestinal tissues from dogs and cats. JAm Vet Med Assoc 2002; 220: 1177-1182.

30. German AJ, Helps CR, Hall EJ et al. Cytokine mRNA expression in mucosal biopsies from German Shepherd dogs with small intesti­nal enteropathies. Dig Dis Sci 2000; 45: 7-17.

31. Vernau WM, Moore PF. An immunophenotypic study of canine leukemias and preliminary assessment of clonality by polymerase chain reaction. Vet Immunol Immunopathol 1999; 69: 145-164.

32. Jergens AE, Schreiner CA, Frank DE et al. A scoring index for dis­ease activity in canine inflammatory bowel disease. J Vet Intern Med 2003;17: 291-297.

33. Hawthorne AB, Daneshmend TK, Hawkey CJ et al. Treatment of ulcerative colitis with fish oil supplementation: a prospective 12 month randomised controlled trial. Gut 1992; 33: 922-928.

34. Belluzzi A, Brignola C, Campieri M et al. Effect of an enteric-coated fish-oil preparation on relapses in Crohn's disease.

35. Wagner RD, Warner T, Roberts L et al. Colonization of congenitally immunodeficient mice with probiotic bacteria. Infect Immunity 1997; 65: 3345-3351.

36. Mitsuyama K, Toyobaga M, Sata M. Intestinal microflora as a thera­peutic target in inflammatory bowel disease. J Gastroenterol 2002; 37 suppl.14: 73-77.

37. Hostutler RA, Luria BJ, Johnson SE et al. Antibiotic-responsive his­tiocytic ulcerative colitis in 9 dogs. J Vet Intern Med 2004; 18: 499­504.

38. Davies DR, O'Hara AJ, Irwin PJ et al. Successful management of histiocytic ulcerative colitis with enrofloxacin in two Boxer dogs. Aust Vet J 2004; 82: 58-61.

39. Travis S. Recent advances in immunomodulation in the treatment of inflammatory bowel disease. Eur J Gastroenterol Hepatol 2003; 15: 215-218.

40. Stewart A. The use of a novel formulation of budesonide as an im­proved treatment over prednisone for inflammatory bowel disease. Proceedings of the 15th ACVIM Forum, 1997; p. 662 (abstract).

41. Tumulty JW, Broussard JD, Steiner JM et al. Clinical effects of short­term oral budesonide on the hypothalamic-pituitary-adrenal axis in dogs with inflammatory bowel disease (IBD). J Am Anim Hosp Assoc 2004; 40: 120-123.

42. Salavaggione OE, Kidd L, Prondzinski JL et al. Canine red blood cell thiopurine S-methyltransferase: companion animal pharmacogenet­ics. Pharmacogenetics 2002; 12: 713-724.

43. Fraser AG. Methotrexate: first-line or second-line immunomodula­tor? Eur J Gastroenterol Hepatol 2003; 15: 225-231.

44. Sandborn WJ. Cyclosporine therapy for inflammatory bowel disease - definitive answers and remaining questions. Gastroenterology 1995; 109: 1001-1003.

45. Hawthorne AB. Ciclosporin and refractory colitis. EurJ Gastroenterol Hepatol 2003; 15: 239-244.

46. Allenspach K, Rufenacht S, Sauter S. et al. Pharmacokinetics and clinical efficacy of cyclosporine treatment of dogs with steroid refractory inflammatory bowel disease. J Vet Intern Med 2006; 20: 239-244.

47. Forbes A. Alternative immunomodulators. EurJ Gastroenterol Hepatol 2003;15: 245-248.

48. Neurath MF, Wanitschke R, Peters M et al. Randomised trial of mycophenolate mofetil versus azathioprine for treatment of chronic active Crohn's disease. Gut 1999; 44: 625-628.

49. Ehrenpreis ED, Kane SV, Cohen LB et al. Thalidomide therapy for patients with refractory Crohn's disease: an open-label trial. Gastro­enterology 1999; 117: 1271-1277.

50. Bauditz J, Haemling J, Ortner M et al. Treatment with tumour necrosis factor inhibitor oxpentifylline does not improve corticos­teroid dependent chronic active Crohn's disease. Gut 1997; 40: 470­474.

51. D'Haens G, Van Deventer S, Van Hogezand R et al. Endoscopic and histological healing with infliximab anti-tumor necrosis factor anti­bodies in Crohn's disease: A European multicenter trial. Gastroenter­ology 1999; 116: 1029-1034.

52. Breitschwerdt EB, Halliwell WH, Foley CW et al. A hereditary di- arrhetic syndrome in the Basenji characterized by malabsorption, protein losing enteropathy and hypergammaglobulinemia. J Am Anim Hosp Assoc 1980; 16: 551-560.

53. Littman MP, Giger U. Familial protein losing enteropathy (PLE) and/or protein losing nephropathy (PLN) in Soft-coated Wheaten Terriers (SCWT);222 cases (1983-1997).J Vet Intern Med 2000; 14: 68-80.

54. Lothrop Jr CD et al. Immunological characterization of intestinal lesions in Basenji dogs with inflammatory bowel disease. Proceedings of the 15th ACVIM Forum, 1997; 662 (abstract).

55. Vaden SL, Sellon RK, Melgarejo LT et al. Evaluation of intestinal permeability and gluten sensitivity in Soft-coated Wheaten Terriers with familial protein-losing enteropathy, protein-losing nephropathy, or both. Am J Vet Res 2000; 61: 518-524.

56. Vaden SL, Hammerberg B, Davenport DJ et al. Food hypersensitivity reactions in Soft-coated Wheaten Terriers with protein-losing enter­opathy or protein-losing nephropathy or both: gastroscopic food sensitivity testing, dietary provocation, and fecal immunoglobulin E.

57. Kovacevic A, Lang J, Lombardi CW Thrombosis of the pulmonary trunk in a Soft-coated Wheaten Terrier as a complication of a pro­tein-losing nephropathy; a case report. Kleintierpraxis 2002; 47: 549­552.

58. Regnier A, Delverdier M, Dossin O. Segmental eosinophilic enteri­tis mimicking intestinal tumors in a dog. Canine Pract 1996; 21: 25­29.

59. Van der Gaag I, Happe RP, Wolvekamp WTC. Eosinophilic enteritis complicated by partial ruptures and a perforation of the small intes­tine in a dog. J Small Anim Pract 1983; 24: 575-581.

60. Baggiolini M. Chemokines and leucocyte traffic. Nature 1998; 392: 565-568.

61. Bright RM, Jenkins C, DeNovo R et al. Chronic diarrhea in a dog with regional granulomatous enteritis. J Small Anim Pract 1994; 35: 423-426.

62. Lewis DC. Successful treatment of regional enteritis in a dog. J Am Anim Hosp Assoc 1995; 31: 170-173.

63. Stokes JE, Kruger JM, Mullaney T et al. Histiocytic ulcerative colitis in three non-Boxer dogs. J Am Anim Hosp Assoc 2001; 37: 461-465.

64. Cooper DM, Gebhart CJ. Comparative aspects of proliferative en­teritis. J Am Vet Med Assoc 1998; 212: 1446-1451.

9.3